Xylo Technologies (Xylo Technologies) Cash-to-Debt : 1.28 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Xylo Technologies Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Xylo Technologies's cash to debt ratio for the quarter that ended in Dec. 2023 was 1.28.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Xylo Technologies could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Xylo Technologies's Cash-to-Debt or its related term are showing as below:

XYLO' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.28 Med: 5104.5 Max: No Debt
Current: 1.28

During the past 12 years, Xylo Technologies's highest Cash to Debt Ratio was No Debt. The lowest was 1.28. And the median was 5104.50.

XYLO's Cash-to-Debt is ranked worse than
56.5% of 862 companies
in the Medical Devices & Instruments industry
Industry Median: 2.03 vs XYLO: 1.28

Xylo Technologies Cash-to-Debt Historical Data

The historical data trend for Xylo Technologies's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Xylo Technologies Cash-to-Debt Chart

Xylo Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

46.29

209.00

16.92

2.47

1.28

Xylo Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															16.92	1.70	2.47	1.26	1.28

Competitive Comparison of Xylo Technologies's Cash-to-Debt

For the Medical Devices subindustry, Xylo Technologies's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xylo Technologies's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xylo Technologies's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Xylo Technologies's Cash-to-Debt falls into.

Xylo Technologies Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Xylo Technologies's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	12.536	/	(9.084	+	0.702)
	=	1.28

Xylo Technologies's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	12.536	/	(9.084	+	0.702)
	=	1.28

Xylo Technologies (NAS:XYLO) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Xylo Technologies Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Xylo Technologies's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Xylo Technologies (Xylo Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xylo Technologies Ltd (NAS:XYLO) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

2QM0:Germany

Address

10 Hanechoshet Street, 4th Floor, Tel Aviv, ISR, 6971072

Website

https://www.medigus.com

Medigus Ltd is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company also develops a range of micro video cameras under the micro ScoutCam portfolio of products. It operates in five segments: Medical, E-Commerce, Online, Electric Vehicles, and Corporate. The company's geographical segments include the United States, United Kingdom, Germany, Israel, China, and Others.